MyAverix Finance
F · Healthcare
VYTRUS BIOTECH EO -01 (V5P)
Biotechnology
VYTRUS BIOTECH EO -01 (V5P) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for V5P
VYTRUS BIOTECH EO -01 (V5P) — FAQ
What is V5P's P/E ratio?
The price-to-earnings (P/E) ratio for VYTRUS BIOTECH EO -01 (V5P) is 25.00 (data as of 2026-05-23).
Does VYTRUS BIOTECH EO -01 pay a dividend?
Dividend yield is not available in the current snapshot for VYTRUS BIOTECH EO -01 (V5P). Check the MyAverix Finance app for the latest dividend data.
What sector is VYTRUS BIOTECH EO -01 in?
VYTRUS BIOTECH EO -01 (V5P) is classified in the Healthcare sector (Biotechnology industry).
What exchange is V5P listed on?
V5P is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.